Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

BACKGROUND: Distinguishing endocervical adenocarcinoma (ECA) from endometrial mucinous adenocarcinoma (EMMA) is clinically significant in view of the differences in their management and prognosis. In this study, we used a panel of tumor markers to determine their ability to distinguish between prima...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Khoury, Thaer, Tan, Dongfeng, Wang, Jianmin, Intengan, Marilyn, Yang, Jun, Alrawi, Sadir, Yan, Peisha, Byrd, James C
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2006
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1382242/
https://ncbi.nlm.nih.gov/pubmed/16409624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6890-6-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים